Pharmaceuticals, Biotechnology and Life Sciences
Data Demonstrated Quantitative Repeatability and Stability of Signal Company Continues to Enroll Subjects as Planned to Complete the Phase 2B…
CROs eliminating manual processes and modernizing systems to streamline information exchange and accelerate study start-up PLEASANTON, Calif.–(BUSINESS WIRE)–#CROs–Contract research organizations…
VIENNA, Va.–(BUSINESS WIRE)–CEL-SCI Corporation (NYSE American: CVM), a Phase 3 cancer immunotherapy company, today announced that Geert Kersten, Chief Executive…
BOSTON–(BUSINESS WIRE)–Gelesis, a biotechnology company developing a novel hydrogel platform technology to treat obesity and other chronic diseases related to…
— Renowned Genetics Researcher Dr. Michael Hayden Appointed Scientific Advisory Board Chair — CAMBRIDGE, Mass.–(BUSINESS WIRE)–CAMP4 Therapeutics, a biotechnology company…
FRIENDSWOOD, Texas–(BUSINESS WIRE)–Castle Biosciences, Inc. (Nasdaq: CSTL), a skin cancer diagnostics company providing personalized genomic information to improve cancer treatment…
Total product and royalty revenues of $534 million (+24% vs. Q3 2018) and Jakafi® (ruxolitinib) revenues of $433 million (+25%…
CAMBRIDGE, England & BOSTON–(BUSINESS WIRE)–Bicycle Therapeutics plc (NASDAQ: BCYC), a biotechnology company pioneering a new and differentiated class of therapeutics…
Sales of $577 million were flat as reported and grew 1% in constant currency Pharmaceutical growth of 3%, partially offset…
Third-Quarter 2019 Worldwide Sales Were $12.4 Billion, an Increase of 15%; Sales Increased 16% Excluding Impact from Foreign Exchange; Growth…